• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在基层医疗中自行报告的减少或停止抗抑郁药物的原因:纵向研究的主题分析。

Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the longitudinal study.

机构信息

Department of General Practice, The University of Melbourne, Melbourne, VIC, 3004, Australia.

Research Department of Primary Care and Population Health, University College, London, NW3 2PF, UK.

出版信息

Prim Health Care Res Dev. 2023 Feb 27;24:e16. doi: 10.1017/S1463423623000038.

DOI:10.1017/S1463423623000038
PMID:36843079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9972355/
Abstract

BACKGROUND

Current treatment guidelines advise that the deprescribing of antidepressants should occur around 6 months post-remission of symptoms. However, this is not routinely occurring in clinical practice, with between 30% and 50% of antidepressant users potentially continuing treatment with no clinical benefit. To support patients to deprescribe antidepressant treatment when clinically appropriate, it is important to understand what is important to patients when making the decision to reduce or cease antidepressants in a naturalistic setting.

AIM

The current study aimed to describe the self-reported reasons primary care patients have for reducing or stopping their antidepressant medication.

METHODS

Three hundred and seven participants in the longitudinal study reported taking an SSRI/SNRI over the life of the study. Of the 307, 179 reported stopping or tapering their antidepressant during computer-assisted telephone interviews and provided a reason for doing so. A collective case study approach was used to collate the reasons for stopping or tapering.

FINDINGS

Reflexive thematic analysis of patient-reported factors revealed five overarching themes; 1. Depression; 2. Medication; 3. Healthcare system; 4. Psychosocial, and; 5. Financial. These findings are used to inform suggestions for the development and implementation of antidepressant deprescribing discussions in clinical practice.

摘要

背景

目前的治疗指南建议,在症状缓解后 6 个月左右应停止使用抗抑郁药。然而,这在临床实践中并没有常规发生,有 30%至 50%的抗抑郁药使用者可能继续接受治疗,但没有临床获益。为了支持患者在临床适当的情况下停止使用抗抑郁药物,了解患者在自然环境中决定减少或停止使用抗抑郁药物时的重要因素是很重要的。

目的

本研究旨在描述初级保健患者在减少或停止抗抑郁药物治疗时自我报告的原因。

方法

在这项纵向研究中,有 307 名参与者报告在研究期间服用了 SSRI/SNRI。在这 307 名参与者中,有 179 名在计算机辅助电话访谈中报告停止或逐渐减少他们的抗抑郁药物,并提供了停止或减少的原因。采用集体案例研究方法来整理停止或减少的原因。

结果

对患者报告的因素进行反思性主题分析揭示了五个总体主题:1. 抑郁;2. 药物;3. 医疗保健系统;4. 心理社会;5. 财务。这些发现用于为临床实践中抗抑郁药物减少讨论的制定和实施提供建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc5/9972355/2e2bc70fa8d2/S1463423623000038_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc5/9972355/3cd97e65d476/S1463423623000038_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc5/9972355/2e2bc70fa8d2/S1463423623000038_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc5/9972355/3cd97e65d476/S1463423623000038_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc5/9972355/2e2bc70fa8d2/S1463423623000038_fig2.jpg

相似文献

1
Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the longitudinal study.在基层医疗中自行报告的减少或停止抗抑郁药物的原因:纵向研究的主题分析。
Prim Health Care Res Dev. 2023 Feb 27;24:e16. doi: 10.1017/S1463423623000038.
2
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.在初级保健中使用抗抑郁药物预防抑郁症复发:ANTLER RCT。
Health Technol Assess. 2021 Nov;25(69):1-62. doi: 10.3310/hta25690.
3
Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.理解澳大利亚普通实践患者在 WiserAD 试验中决定减少抗抑郁药使用的决策:一种基于现实主义的方法。
BMJ Open. 2024 Feb 13;14(2):e078179. doi: 10.1136/bmjopen-2023-078179.
4
Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.全科医生对抗抑郁药减药的观点探索:一项定性研究。
BMJ Open. 2021 Apr 5;11(4):e046054. doi: 10.1136/bmjopen-2020-046054.
5
Social media group support for antidepressant deprescribing: a mixed-methods survey of patient experiences.社交媒体群组对抗抑郁药减药的支持:一项基于患者经验的混合方法调查。
Aust J Prim Health. 2024 May;30. doi: 10.1071/PY23046.
6
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.联合米氮平与 SSRIs 或 SNRIs 治疗难治性抑郁症:MIR RCT。
Health Technol Assess. 2018 Nov;22(63):1-136. doi: 10.3310/hta22630.
7
Antidepressant treatment for primary care patients with depressive symptoms: Data from the longitudinal cohort study.针对有抑郁症状的基层医疗患者的抗抑郁治疗:来自纵向队列研究的数据。
Aust N Z J Psychiatry. 2020 Apr;54(4):367-381. doi: 10.1177/0004867419898761. Epub 2020 Jan 20.
8
Antidepressants for people with epilepsy and depression.抗抑郁药治疗癫痫合并抑郁患者。
Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3.
9
Antidepressants for people with epilepsy and depression.用于癫痫伴抑郁症患者的抗抑郁药。
Cochrane Database Syst Rev. 2014 Dec 3;2014(12):CD010682. doi: 10.1002/14651858.CD010682.pub2.
10
[Antidepressants consumption in the global population in France].[法国全球人口中的抗抑郁药消费情况]
Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7.

引用本文的文献

1
'I Wish It Were More Often Told to People Before They Are Prescribed These Medications How Hard It Is to Get Off Them': A Qualitative Descriptive Analysis of Free-Text Responses to a Survey on Reducing and Stopping Psychiatric Medication.“我希望在给人们开这些药之前,能更经常地告诉他们停药有多难”:对一项关于减少和停用精神科药物的调查的自由文本回复的定性描述性分析
Health Expect. 2025 Aug;28(4):e70384. doi: 10.1111/hex.70384.
2
Psychosocial Impact of Postmastectomy Lymphedema Syndrome: Insights From a National Claims Database Analysis of Antidepressant Prescription Fills.乳房切除术后淋巴水肿综合征的心理社会影响:来自抗抑郁药物处方配药全国索赔数据库分析的见解
Plast Reconstr Surg Glob Open. 2025 Aug 5;13(8):e7012. doi: 10.1097/GOX.0000000000007012. eCollection 2025 Aug.
3

本文引用的文献

1
Description of antidepressant withdrawal symptoms in clinical practice guidelines on depression: A systematic review.临床实践指南中对抑郁症的描述:抗抑郁药停药症状的系统评价。
J Affect Disord. 2022 Nov 1;316:177-186. doi: 10.1016/j.jad.2022.08.011. Epub 2022 Aug 12.
2
Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study.我应该吗?我能够吗?我敢吗?患者对停止长期使用抗抑郁药的看法,一项定性研究。
Acta Clin Belg. 2022 Dec;77(6):962-969. doi: 10.1080/17843286.2021.2024384. Epub 2022 Jan 10.
3
'Never change a winning team': GPs' perspectives on discontinuation of long-term antidepressants.
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial.艾氯胺酮单药治疗成人难治性抑郁症:一项随机临床试验。
JAMA Psychiatry. 2025 Jul 2. doi: 10.1001/jamapsychiatry.2025.1317.
4
Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.患者对抑郁症治疗中药物依从性的障碍和促进因素的认知:一项定性研究。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241286313. doi: 10.1177/21501319241286313.
5
Role of primary care in depression relapse: a qualitative study.基层医疗在抑郁症复发中的作用:一项定性研究。
Br J Gen Pract. 2025 Mar 27;75(753):e292-e299. doi: 10.3399/BJGP.2024.0384. Print 2025 Apr.
6
Carers' experiences and perspectives of the use of anticholinergic medications in people living with dementia: Analysis of an online discussion forum.照顾者对痴呆症患者使用抗胆碱能药物的体验和看法:对在线讨论论坛的分析。
Health Expect. 2024 Feb;27(1):e13972. doi: 10.1111/hex.13972.
7
Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.理解澳大利亚普通实践患者在 WiserAD 试验中决定减少抗抑郁药使用的决策:一种基于现实主义的方法。
BMJ Open. 2024 Feb 13;14(2):e078179. doi: 10.1136/bmjopen-2023-078179.
“切勿更换成功的治疗团队”:全科医生对长期抗抑郁药停药的看法。
Scand J Prim Health Care. 2021 Dec;39(4):533-542. doi: 10.1080/02813432.2021.2006487. Epub 2021 Dec 11.
4
Deprescribing intervention activities mapped to guiding principles for use in general practice: a scoping review.针对一般实践中使用的指导原则进行的药物减量干预活动的制定:范围综述。
BMJ Open. 2021 Sep 6;11(9):e052547. doi: 10.1136/bmjopen-2021-052547.
5
The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.2020 年澳大利亚皇家精神科医学院和新西兰精神科医学院心境障碍临床实践指南。
Aust N Z J Psychiatry. 2021 Jan;55(1):7-117. doi: 10.1177/0004867420979353.
6
Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.初级医疗保健中基于行为改变轮的药物减量干预措施:范围综述。
Res Social Adm Pharm. 2021 Jul;17(7):1229-1241. doi: 10.1016/j.sapharm.2020.09.005. Epub 2020 Sep 22.
7
Antidepressant treatment for primary care patients with depressive symptoms: Data from the longitudinal cohort study.针对有抑郁症状的基层医疗患者的抗抑郁治疗:来自纵向队列研究的数据。
Aust N Z J Psychiatry. 2020 Apr;54(4):367-381. doi: 10.1177/0004867419898761. Epub 2020 Jan 20.
8
NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms.英国国家卫生与临床优化研究所更新抗抑郁药指南,以反映戒断症状的严重程度和持续时间。
BMJ. 2019 Oct 18;367:l6103. doi: 10.1136/bmj.l6103.
9
Causes of drug discontinuation in patients with major depressive disorder in China.中国重度抑郁症患者停药的原因。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109755. doi: 10.1016/j.pnpbp.2019.109755. Epub 2019 Aug 24.
10
Helping people discontinue long-term antidepressants: views of health professionals in UK primary care.帮助人们停止长期使用抗抑郁药:英国初级保健中卫生专业人员的观点。
BMJ Open. 2019 Jul 4;9(7):e027837. doi: 10.1136/bmjopen-2018-027837.